Skip to main content

Highlights

  1. 1
    Journal of cardiac failure · 2020
    PMID: 32956813PMCID: PMC7501531DOIFirst author11 citations

Publications

23 publications

Funding

1 grant

Active

1 grant
  • KP
    A novel wearable to study cerebrovascular physiology underlying cognition in end-stage heart failure and LVAD patients
    American Heart Association · 2024–2026
    AHA 24IPA1275206

Clinical research

5 studies

Active

3 studies
  • PI
    A Retrospective Chart Review of Scleroderma Patients at HSS and NYP
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
  • PI
    A Retrospective Chart Review of Sarcoidosis Patients at HSS and NYP
    Hospital for Special Surgery · OPEN TO ACCRUAL (as of 2025)
  • PI
    Delayed ARIES: Aspirin and Hemocompatibility Events in Advanced Heart Failure Patients Chronically Supported With a Left Ventricular Assist Device
    PHASE4 · NYP/Columbia · OPEN TO ACCRUAL (as of 2025)
    Bleeding; Clot Blood
    NCT06655376
Completed & closed trials (2)
  • PI
    A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Study to Evaluate the Efficacy and Safety of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)
    PHASE2 · Gossamer Bio · IRB STUDY CLOSURE (as of 2023)
    Pulmonary Artery Hypertension
    NCT04456998
  • PI
    An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)
    PHASE2 · Gossamer Bio · CLOSED TO ACCRUAL (as of 2022)
    Pulmonary Arterial Hypertension
    NCT04816604